Promega Corporation this week is hosting a hands-on research academy for colorectal cancer survivors, caregivers and other members of the Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) program.
Pharmaceutical Industry News
Biodesix, Inc., has been issued U.S. Patent Number 10,422,729, which covers the Biodesix Collection Device (BCD). The new device offers improved ease of use in blood sample collection for diagnostic testing, compared to current standard methods.
The first CAR T cell therapy targeting the B cell-activating factor receptor on cancerous cells eradicated CD19-targeted therapy-resistant human leukemia and lymphoma cells in animal models, according to City of Hope research published today in Science Translational Medicine.
Between 1.7 and 3 million sports and recreation-related concussions happen each year, 300,000 of which are football-related, according to the statistics collected by the UPMC Sports Medicine Concussion Program.
Apex Physics Partners (APP), a leading medical physics business services support organization, is proud to announce partnerships with Ohio Medical Physics Consulting (OMPC), National Physics Consultants (NPC), Radiological Physics (RPI) and ZapIT! QA.
Sight Sciences announced clinical results from the first study of the OMNI® Surgical System in glaucoma patients were presented at the European Society of Cataract and Refractive Surgery (ESCRS).
Gelymar S.A, the third largest carrageenan producer globally, completed this week its capacity expansion program initiated 24 months ago with a US$15M investment. Its production capacity is now doubled at about 10,000 metric tons of product.
MTF Biologics, a leading nonprofit tissue bank dedicated to saving and healing lives, will be featuring its line of placental and dermal wound care innovations at this year’s Symposium on Advanced Wound Care (SAWC) Spring | Wound Health Society Meeting.
Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications...
Life-saving naloxone, an emergency drug used to reverse a potentially fatal opioid overdose, is now available to businesses and organizations in Texas for online purchase and delivery at www.NaloxoneExchange.com, the company Fiduscript announced Thursday.